Industry Symposium 21

12:15-13:15   Hall K

Secondary Carnitine Deficiency in Dialysis Patients-Shall We Supplement it?

Chairs: Ronald Wanders, Amsterdam, The Netherlands
            Tim Ulinski, Paris, France

Carnitine in Human Health and Disease Including Genetic Metabolic Disorders
Ronald J.A.Wanders, Amsterdam, The Netherlands
Characteristics of Dialysis-Related Carnitine Deficiency - Effectiveness of L-carnitine for the
Treatment of Erythropoietin-Resistant Renal Anaemia
Stephanie Reuter Lange, Adelaide, Australia
Carnitine Levels, Myocardial Function and Survival Outcomes in Children Receiving Chronic
Hemodialysis and Continuous Renal Replacement Therapy
Asha Moudgil, Washington, U.S.A.

Organised by SIGMA-TAU

back to timetable

final programme "day by day" - may 21 - 24, 2016